Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI)
Klinikum / Johannes Gutenberg-Universität Mainz
Loquai, Carmen; Dechent, Dagmar; Garzarolli, Marlene et al.
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanomaMEDICAL ONCOLOGY. Bd. 33. H. 5. 2016
Chen, Tianhui; Fallah, Mahdi; Brenner, Hermann et al.
Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer RegistriesSCIENTIFIC REPORTS. Bd. 6. 2016
Azaripour, Adriano; Kissinger, Maren; Farina, Vittorio Siro Leone et al.
Root coverage with connective tissue graft associated with coronally advanced flap or tunnel technique: a randomized, double-blind, mono-centre clinical trialJOURNAL OF CLINICAL PERIODONTOLOGY. Bd. 43. H. 12. 2016 S. 1142-1150
Gunst, Diana Christine Maria; Kaatsch, Peter; Goldbeck, Lutz
Seeing the good in the bad: which factors are associated with posttraumatic growth in long-term survivors of adolescent cancer?SUPPORTIVE CARE IN CANCER. Bd. 24. H. 11. 2016 S. 4607-4615
Sagheb, Keyvan; Sagheb, Kawe; Rahimi-Nedjat, Roman et al.
Sentinel lymph node biopsy in T1/T2 squamous cell carcinomas of the tongue: A prospective studyONCOLOGY LETTERS. Bd. 11. H. 1. 2016 S. 600-604
Abegunewardene, Nico; Kreitner, Karl-Friedrich; Oberholzer, Katja et al.
Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarctionCLINICAL HEMORHEOLOGY AND MICROCIRCULATION. Bd. 62. H. 4. 2016 S. 345-357
Panova-Noeva, Marina; Schulz, Andreas; Hermanns, M. Iris et al.
Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health StudyBLOOD. Bd. 127. H. 2. 2016 S. 251-259
Schwentner, L.; Harbeck, N.; Singer, S. et al.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized Adebar trialCANCER RESEARCH. Bd. 76. 2016
Schwentner, L.; Harbeck, N.; Singer, S. et al.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized Adebar trialCANCER RESEARCH. Bd. 76. 2016
Schwentner, Lukas; Harbeck, Nadia; Singer, Susanne et al.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trialBREAST. Bd. 27. 2016 S. 69-77